1,391 Shares in Solventum Co. (NYSE:SOLV) Acquired by SYSTM Wealth Solutions LLC

SYSTM Wealth Solutions LLC acquired a new position in shares of Solventum Co. (NYSE:SOLVFree Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,391 shares of the company’s stock, valued at approximately $74,000.

A number of other institutional investors also recently bought and sold shares of the company. Deseret Mutual Benefit Administrators acquired a new position in shares of Solventum during the 2nd quarter worth $25,000. Partnership Wealth Management LLC purchased a new position in Solventum during the 2nd quarter valued at about $26,000. Richard W. Paul & Associates LLC acquired a new position in Solventum during the second quarter worth about $26,000. Family Firm Inc. purchased a new stake in shares of Solventum in the second quarter valued at about $26,000. Finally, M&R Capital Management Inc. acquired a new stake in shares of Solventum in the second quarter valued at approximately $27,000.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on SOLV shares. The Goldman Sachs Group upped their target price on Solventum from $48.00 to $54.00 and gave the company a “sell” rating in a research note on Monday, August 12th. Bank of America decreased their price objective on Solventum from $70.00 to $60.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 25th. Morgan Stanley cut their target price on shares of Solventum from $70.00 to $55.00 and set an “equal weight” rating for the company in a research note on Monday, July 15th. BTIG Research began coverage on shares of Solventum in a research note on Thursday, September 5th. They set a “neutral” rating on the stock. Finally, Argus started coverage on shares of Solventum in a research report on Monday, June 24th. They issued a “hold” rating for the company. One analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. According to MarketBeat.com, Solventum presently has an average rating of “Hold” and an average price target of $58.25.

Check Out Our Latest Analysis on Solventum

Solventum Trading Up 0.3 %

NYSE SOLV opened at $72.32 on Friday. The stock’s 50-day simple moving average is $60.59. The company has a current ratio of 1.31, a quick ratio of 0.96 and a debt-to-equity ratio of 2.90. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05.

Solventum (NYSE:SOLVGet Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.10. The company had revenue of $2.08 billion for the quarter, compared to analysts’ expectations of $2.05 billion. The firm’s quarterly revenue was up .2% compared to the same quarter last year. As a group, research analysts anticipate that Solventum Co. will post 6.38 earnings per share for the current year.

Solventum Profile

(Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Recommended Stories

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLVFree Report).

Institutional Ownership by Quarter for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.